GlassScriptPhysician profile
Dilip S Arora
NPI 1225098114
$18,099.67
in general payments reported to CMS, 2019-2025
37 companies · $3,567 in 2025
The $3,567 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,334 · 2020: $694 · 2021: $3,846 · 2022: $3,958 · 2023: $1,655 · 2024: $3,046 · 2025: $3,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,093 · Travel and Lodging: $2,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,093.22 |
| Travel and Lodging | $2,175.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,099.41 | 2021-2025 | Corevalve Evolut R, Linq II, Telescope |
| Boston Scientific Corporation | $4,859.93 | 2020-2025 | General - Therapies, Watchman Access System, Ranger |
| Medical Device Business Services, INC. | $1,141.28 | 2024 | Carto 3 |
| Baylis Medical Company INC | $887.76 | 2021 | |
| Edwards Lifesciences Corporation | $698.37 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $581.27 | 2019-2025 | |
| Cook Medical LLC | $565.96 | 2019-2024 | Zenith Alpha, Zenith Spiral-Z |
| Janssen Pharmaceuticals, INC | $484.41 | 2019-2023 | Xarelto |
| Abbott Laboratories | $453.53 | 2019-2025 | Optis, Coroflow, Perclose Proglide |
| Amgen INC. | $427.78 | 2020-2022 | |
| Shockwave Medical, INC | $330.89 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.40 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $292.59 | 2021-2025 | Camzyos, Eliquis |
| Kerecis Limited | $249.09 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Medtronic Vascular, INC. | $237.44 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $197.98 | 2022-2024 | (Az7) Lasers |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.07 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $152.74 | 2020-2023 | Nexletol |
| Heartflow, INC. | $94.04 | 2025 | |
| Terumo Medical Corporation | $93.84 | 2024 | Azur Cx Detachable |
| Angiodynamics, INC. | $82.47 | 2022-2023 | Venacure 1470 Pro |
| Abiomed | $79.05 | 2023-2025 | Impella |
| Chiesi USA, INC. | $75.13 | 2021 | |
| Pfizer INC. | $70.65 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $70.07 | 2019-2024 | Brilinta |
| Biosense Webster, INC. | $62.53 | 2022 | |
| Endologix LLC | $55.81 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $52.98 | 2021-2025 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $32.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.30 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $32.26 | 2025 | Verquvo |
| Amarin Pharma, INC. | $28.95 | 2019 | |
| Daiichi Sankyo INC. | $27.90 | 2023 | Injectafer |
| W. L. Gore & Associates, INC. | $21.38 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Irhythm Technologies, INC. | $20.99 | 2024 | Zio Monitor, Zio Xt Patch |
| Cardiva Medical, INC. | $17.66 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilip Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.